EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Inhibition of amyloid beta oligomer accumulation by NU-9: A unifying mechanism for the treatment of neurodegenerative diseases

Elizabeth A Johnson, Raghad Nowar, Kirsten L Viola, Weijian Huang, Sihang Zhou iD, Maíra A Bicca, Wei Zhu, Daniel L Kranz, William L Klein, Richard B Silverman iD

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2402117122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Elizabeth A Johnson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Northwestern University, Evanston, IL 60208. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Neurodegenerative Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | National Institutes of Health (NIH), NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein aggregation is a hallmark of neurodegenerative diseases, which connects these neuropathologies by a common phenotype. Various proteins and peptides form aggregates that are poorly degraded, and their ensuing pathological accumulation underlies these neurodegenerative diseases. Similarities may exist in the mechanisms responsible for the buildup of these aggregates. Therefore, therapeutics designed to treat one neurodegenerative disease may be beneficial to others. In ALS models, the compound NU-9 was previously shown to block neurodegeneration produced by aggregation-inducing mutations of SOD-1 and TDP-43 [B. Genç et al., Clin. Transl. Med. 11 , e336 (2021)]. Here, we report that NU-9 also prevents the accumulation of amyloid beta oligomers (AβOs), small peptide aggregates that are instigators of Alzheimer’s disease neurodegeneration [M. Tolar et al., Int. J. Mol. Sci. 22 , 6355 (2021)]. AβO buildup was measured by immunofluorescence imaging of cultured hippocampal neurons exposed to exogenous monomeric Aβ. In this model, AβO buildup occurs via cathepsin L- and dynamin-dependent trafficking. This is prevented by NU-9 through a cellular mechanism that is cathepsin B- and lysosome-dependent, suggesting that NU-9 enhances the ability of endolysosomal trafficking to protect against AβO buildup. This possibility is strongly supported by a quantitative assay for autophagosomes that shows robust stimulation by NU-9. These results contribute additional understanding to the mechanisms of protein aggregation and suggest that multiple neurodegenerative diseases might be treatable by targeting common pathogenic mechanisms responsible for protein aggregation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-PeptidesNeurodegenerative DiseasesHumansAnimalsNeuronsHippocampusMiceAutophagyProtein Aggregation, PathologicalAlzheimer DiseaseLysosomesProtein Aggregates

Stichwörter der Autor:innen

Alzheimer’s diseaseamyloid-beta oligomersneurodegenerative diseaseprotein aggregation

Substanzen

Amyloid beta-PeptidesProtein Aggregates

Autor:innen und Institutionen

  • Department of Chemistry, Northwestern University, Evanston, IL 60208.
  • Chemistry of Life Processes Institute, Northwestern University, Evanston, IL 60208.
  • Department of Neurobiology, Northwestern University, Evanston, IL 60208.
  • The Master of Biotechnology Program, McCormick School of Engineering, Northwestern University, Evanston, IL 60208.
  • Department of Neurology, Northwestern University, Chicago, IL 60611.
  • Department of Molecular Biosciences, Northwestern University, Evanston, IL 60208.

ORCID-Profile: Sihang Zhou, Richard B Silverman

Förderung

  • HHS | National Institutes of Health (NIH)
  • NIH HHS
  • NIA NIH HHS

Zitieren

APA

Johnson, E. A., Nowar, R., Viola, K. L., Huang, W., Zhou, S., Bicca, M. A., Zhu, W., Kranz, D. L., Klein, W. L., & Silverman, R. B. (2025). Inhibition of amyloid beta oligomer accumulation by NU-9: A unifying mechanism for the treatment of neurodegenerative diseases. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2402117122

Vancouver

Johnson EA, Nowar R, Viola KL, Huang W, Zhou S, Bicca MA, et al. Inhibition of amyloid beta oligomer accumulation by NU-9: A unifying mechanism for the treatment of neurodegenerative diseases. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2402117122

BibTeX
@article{Johnson2025,
  author = {Johnson, Elizabeth A and Nowar, Raghad and Viola, Kirsten L and Huang, Weijian and Zhou, Sihang and Bicca, Maíra A and Zhu, Wei and Kranz, Daniel L and Klein, William L and Silverman, Richard B},
  title = {Inhibition of amyloid beta oligomer accumulation by NU-9: A unifying mechanism for the treatment of neurodegenerative diseases},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2402117122}
}
Kostenlos starten →